AVNS Market Analysis
News & Sentiment
49 articles · sorted by datePage 1 of 3 · 49 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—Forward 30.67
EPS (TTM)$-1.60-21.7% YoY
Profit margin-10.4%HEALTHCARE
Market cap$1.17BSmall cap
Valuation
- Forward P/E
- 30.67
- PEG ratio
- —
- P/B
- 1.50
- P/S (TTM)
- 1.64
- EV/EBITDA
- 17.17
Profitability & growth
- ROE (TTM)
- -9.2%
- Operating margin
- 5.4%
- Revenue growth YoY
- 8.8%
- Dividend yield
- —
- Beta
- 1.57
Last earnings
May 5, 2026 · Estimate $0.14 · Reported $0.22
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Avanos Medical Inc
Company profileAvanos Medical, Inc. is a medical technology company focused on providing medical device solutions to improve the quality of life for patients in North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America. The company is headquartered in Alpharetta, Georgia.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 5405 WINDWARD PARKWAY, ALPHARETTA, GA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$1.17B
Shares outstanding$46.8M
52W high$25.49
52W low$9.30
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent